Literature DB >> 25590231

The neuromuscular junction: measuring synapse size, fragmentation and changes in synaptic protein density using confocal fluorescence microscopy.

Nigel Tse1, Marco Morsch2, Nazanin Ghazanfari1, Louise Cole3, Archunan Visvanathan1, Catherine Leamey1, William D Phillips4.   

Abstract

The neuromuscular junction (NMJ) is the large, cholinergic relay synapse through which mammalian motor neurons control voluntary muscle contraction. Structural changes at the NMJ can result in neurotransmission failure, resulting in weakness, atrophy and even death of the muscle fiber. Many studies have investigated how genetic modifications or disease can alter the structure of the mouse NMJ. Unfortunately, it can be difficult to directly compare findings from these studies because they often employed different parameters and analytical methods. Three protocols are described here. The first uses maximum intensity projection confocal images to measure the area of acetylcholine receptor (AChR)-rich postsynaptic membrane domains at the endplate and the area of synaptic vesicle staining in the overlying presynaptic nerve terminal. The second protocol compares the relative intensities of immunostaining for synaptic proteins in the postsynaptic membrane. The third protocol uses Fluorescence Resonance Energy Transfer (FRET) to detect changes in the packing of postsynaptic AChRs at the endplate. The protocols have been developed and refined over a series of studies. Factors that influence the quality and consistency of results are discussed and normative data are provided for NMJs in healthy young adult mice.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25590231      PMCID: PMC4354481          DOI: 10.3791/52220

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  33 in total

1.  Electron microscopic evidence for nucleation and growth of 3D acetylcholine receptor microcrystals in structured lipid-detergent matrices.

Authors:  Yoav Paas; Jean Cartaud; Michel Recouvreur; Regis Grailhe; Virginie Dufresne; Eva Pebay-Peyroula; Ehud M Landau; Jean-Pierre Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

Review 2.  Muscle specific kinase: organiser of synaptic membrane domains.

Authors:  Nazanin Ghazanfari; Kristine J Fernandez; Yui Murata; Marco Morsch; Shyuan T Ngo; Stephen W Reddel; Peter G Noakes; William D Phillips
Journal:  Int J Biochem Cell Biol       Date:  2010-10-23       Impact factor: 5.085

3.  Morphology of diaphragm neuromuscular junctions on different fibre types.

Authors:  Y S Prakash; S M Miller; M Huang; G C Sieck
Journal:  J Neurocytol       Date:  1996-02

4.  Skeletal muscle IP3R1 receptors amplify physiological and pathological synaptic calcium signals.

Authors:  Haipeng Zhu; Bula J Bhattacharyya; Hong Lin; Christopher M Gomez
Journal:  J Neurosci       Date:  2011-10-26       Impact factor: 6.167

5.  Increasing MuSK activity delays denervation and improves motor function in ALS mice.

Authors:  María J Pérez-García; Steven J Burden
Journal:  Cell Rep       Date:  2012-08-30       Impact factor: 9.423

6.  Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors.

Authors:  Marco Morsch; Stephen W Reddel; Nazanin Ghazanfari; Klaus V Toyka; William D Phillips
Journal:  Exp Neurol       Date:  2012-07-10       Impact factor: 5.330

7.  Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody.

Authors:  Marco Morsch; Stephen W Reddel; Nazanin Ghazanfari; Klaus V Toyka; William D Phillips
Journal:  J Physiol       Date:  2013-02-25       Impact factor: 5.182

8.  Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin.

Authors:  Nadine Schmidt; Mohammed Akaaboune; Nadesan Gajendran; Isabel Martinez-Pena y Valenzuela; Sarah Wakefield; Raphael Thurnheer; Hans Rudolf Brenner
Journal:  J Cell Biol       Date:  2011-12-19       Impact factor: 10.539

9.  Shared resistance to aging and ALS in neuromuscular junctions of specific muscles.

Authors:  Gregorio Valdez; Juan C Tapia; Jeff W Lichtman; Michael A Fox; Joshua R Sanes
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

10.  Sequence of age-associated changes to the mouse neuromuscular junction and the protective effects of voluntary exercise.

Authors:  Anson Cheng; Marco Morsch; Yui Murata; Nazanin Ghazanfari; Stephen W Reddel; William D Phillips
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

View more
  15 in total

1.  Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.

Authors:  Grace M McMacken; Sally Spendiff; Roger G Whittaker; Emily O'Connor; Rachel M Howarth; Veronika Boczonadi; Rita Horvath; Clarke R Slater; Hanns Lochmüller
Journal:  Hum Mol Genet       Date:  2019-07-15       Impact factor: 6.150

2.  Gpr126/Adgrg6 contributes to the terminal Schwann cell response at the neuromuscular junction following peripheral nerve injury.

Authors:  Albina Jablonka-Shariff; Chuieng-Yi Lu; Katherine Campbell; Kelly R Monk; Alison K Snyder-Warwick
Journal:  Glia       Date:  2019-12-24       Impact factor: 7.452

3.  An Invasive Method for the Activation of the Mouse Dentate Gyrus by High-frequency Stimulation.

Authors:  Zhe Zhao; Haitao Wu
Journal:  J Vis Exp       Date:  2018-06-02       Impact factor: 1.355

4.  Determination of a Critical Size Threshold for Volumetric Muscle Loss in the Mouse Quadriceps.

Authors:  Shannon E Anderson; Woojin M Han; Vunya Srinivasa; Mahir Mohiuddin; Marissa A Ruehle; June Young Moon; Eunjung Shin; Cheryl L San Emeterio; Molly E Ogle; Edward A Botchwey; Nick J Willett; Young C Jang
Journal:  Tissue Eng Part C Methods       Date:  2019-02       Impact factor: 3.056

5.  Characterizing the molecular phenotype of an Atp7a(T985I) conditional knock in mouse model for X-linked distal hereditary motor neuropathy (dHMNX).

Authors:  Gonzalo Perez-Siles; Adrienne Grant; Melina Ellis; Carolyn Ly; Aditi Kidambi; Mamdouh Khalil; Roxana M Llanos; Sharon La Fontaine; Alleene V Strickland; Stephan Züchner; Sandra Bermeo; Elysia Neist; Tara C Brennan-Speranza; Reinaldo I Takata; Carlos E Speck-Martins; Julian F B Mercer; Garth A Nicholson; Marina L Kennerson
Journal:  Metallomics       Date:  2016-06-13       Impact factor: 4.526

6.  Secondary denervation is a chronic pathophysiologic sequela of volumetric muscle loss.

Authors:  Jacob R Sorensen; Daniel B Hoffman; Benjamin T Corona; Sarah M Greising
Journal:  J Appl Physiol (1985)       Date:  2021-04-08

7.  In vivo characterization of microglial engulfment of dying neurons in the zebrafish spinal cord.

Authors:  Marco Morsch; Rowan Radford; Albert Lee; Emily K Don; Andrew P Badrock; Thomas E Hall; Nicholas J Cole; Roger Chung
Journal:  Front Cell Neurosci       Date:  2015-08-31       Impact factor: 5.505

8.  Muscle weakness caused by cancer and chemotherapy is associated with loss of motor unit connectivity.

Authors:  Joshua R Huot; Fabrizio Pin; Andrea Bonetto
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

9.  Forced expression of muscle specific kinase slows postsynaptic acetylcholine receptor loss in a mouse model of MuSK myasthenia gravis.

Authors:  Nazanin Ghazanfari; Erna L T B Linsao; Sofie Trajanovska; Marco Morsch; Paul Gregorevic; Simon X Liang; Stephen W Reddel; William D Phillips
Journal:  Physiol Rep       Date:  2015-12-22

10.  Optogenetic approach for targeted activation of global calcium transients in differentiated C2C12 myotubes.

Authors:  Stéphane Sebille; Oualid Ayad; Charles-Albert Chapotte-Baldacci; Christian Cognard; Patrick Bois; Aurélien Chatelier
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.